Hepatitis C Vaccine Shows Promise In Early Clinical Trial

Share this content:
Hepatitis C vaccine shows promise in early clinical trial
Hepatitis C vaccine shows promise in early clinical trial
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). Being born to a mother with HCV can also cause infection. Around 75-85% of people with HCV will develop chronic hepatitis C infection. This indicates that the body is able to produce an immune response to ward off the virus. ...
READ FULL ARTICLE From Medical News Today
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters